E. M. Kamenskih

ORCID: 0000-0003-0814-8344
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heme Oxygenase-1 and Carbon Monoxide
  • Inflammasome and immune disorders
  • Healthcare Systems and Public Health
  • Immune cells in cancer
  • S100 Proteins and Annexins
  • Acute Ischemic Stroke Management
  • Eicosanoids and Hypertension Pharmacology
  • Bone health and treatments
  • Dementia and Cognitive Impairment Research
  • Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • Diabetes and associated disorders
  • Parathyroid Disorders and Treatments
  • Technology and Human Factors in Education and Health
  • Vitamin D Research Studies
  • Neurological Disorders and Treatments
  • Adipokines, Inflammation, and Metabolic Diseases

Siberian State Medical University
2023-2024

One of the latest achievements in field medicine is introduction into practice technologies using computerized training and Virtual Reality (VR), which create new opportunities for prevention, as well treatment people suff ering from various cognitive impairments. Purpose study . The aim to investigate classical (conventional), VR neural interfaces focused on prevention rehabilitation functional changes higher nervous activity. Methods In March 2022, a search was made scientifi c full-text...

10.30629/2658-7947-2022-27-6-5-12 article EN Russian neurological Journal 2023-01-10

10.1134/s0022093024030098 article EN Journal of Evolutionary Biochemistry and Physiology 2024-05-01

Ischemic stroke (IS) is a prevalent condition with high mortality and disability risks worldwide. As of now, the issue pathogenetic therapy remains unresolved due to limited effectiveness safety reperfusion measures. Recent research has elucidated that neuroinflammation plays pivotal role in IS development may serve as therapeutic target. The NLRP3 inflammasome emerges key mediator orchestrating post-ischemic inflammatory reactions through activation caspase-1, which cleaves...

10.31857/s0869813924050014 article EN Российский физиологический журнал им  И  М  Сеченова 2024-10-19

Introduction. Bridging therapy is the main method of treating ischemic stroke (IS) due to proximal occlusion, effectiveness which depends on speed its implementation. It possible increase systemic thrombolytic (STT) and reduce delay before mechanical thrombectomy (MT) by using bolus forms drugs. Aim. To evaluate efficacy safety non-immunogenic staphylokinase compared alteplase in bridging IS real clinical practice a regional center (RSC). Materials methods. A retrospective study combined use...

10.21518/ms2024-487 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-11-07
Coming Soon ...